Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
drugs
7
×
national blog main
life sciences
amgen
boston blog main
cancer
clinical trials
national top stories
calcitonin gene-related peptide
eli lilly
fda
healthcare
healthit
indiana blog main
indiana top stories
innovation
medical devices
migraine
new york blog main
new york top stories
people
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
startups
svb leerink
teva pharmaceutical
texas blog main
texas top stories
vc
venture capital
alder biopharmaceutical
alirocumab
allergan
alnylam pharmaceuticals
american academy of neurology
anti aging
What
new
7
×
drug
drugs
announced
approval
class
fda
latest
life
medicines
migraine
partners
sciences
won
advance
aging
alnylam
alzheimer’s
anti
approved
arguments
based
big
biologic
biology
biotech
cagey
calico
cancer
cash
center
center’s
certainly
cholesterol
commercialized
committed
companies
competitors
cytokine
data
Language
Current search:
drugs
×
biotech
×
new
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@venturebeat.com
7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs